Delivery Order SPE2DB22D3501-SPE2DB24FUV96

Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $3,631.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of...
The U.S. Defense Logistics Agency (DLA) awarded a $14,143.79 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,644.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D3404|SPE2DX24F1ARH) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $18,333.87 contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty pharmaceutical product. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite...
The Defense Logistics Agency (DLA) awarded a $3,287.16 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a $35,769.87 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This contract has an ultimate completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,235.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This contract is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The contract has a potential value of $7,890.82 and a completion date of March 1, 2024. This award is under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a $11,279.88 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FUV96
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,483.24 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a pharmaceutical product, to DLA Troop Support Medical facilities. This order is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. No set-aside designation was used for this contract award.

Generated 6/7/24, 9:07 AM